| Jessica Jozefiak, LMFT | |
|
909 Hidden Valley Rd, Pownal, VT 05261-9302 | |
| (305) 308-5977 | |
| Not Available |
| Full Name | Jessica Jozefiak |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 909 Hidden Valley Rd, Pownal, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205579372 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 100.0314017 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Jozefiak, LMFT 909 Hidden Valley Rd, Pownal, VT 05261-9302 Ph: (305) 308-5977 | Jessica Jozefiak, LMFT 909 Hidden Valley Rd, Pownal, VT 05261-9302 Ph: (305) 308-5977 |
News Archive
Premiums in California's health insurance exchange will rise by an average of 8.7 percent next year, marking a return to more modest increases despite ongoing threats to the Affordable Care Act.
Approximately 21 million visits were made to physicians' offices due to back problems in 2006. While countless adults experience back pain and stiffness, many suffer from serious spine and back conditions -including injury, herniated discs and the deterioration of the vertebrae. Three new studies presented at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) detail advances in back care and treatment options for specific back and spine conditions.
SIPPET, a study which involved 42 centers in 14 countries in Europe, North and South America, Africa and Asia was designed to definitively settle the long-debated question whether factor VIII concentrates from different sources (plasma-derived containing VWF or recombinant technology) differ in risk of inhibitor development in previously untreated children (PUPs) with severe hemophilia A.
A new mobile phone app, the first of its kind, helps concussion patients track their activities and symptoms, and share that information with their healthcare team. The app from the University of Michigan, is called Return2Play.
Pivotal, a European-wide full-service CRO, has announced today that it has been contracted to provide specialized clinical research services in a clinical trial to study the efficacy and safety of hyperimmune plasma, obtained from cured and convalescent COVID-19 patients, in the treatment of hospitalized patients with COVID-19 who are admitted in an acute phase.
› Verified 5 days ago